| Date Filed | Type | Description |
| 08/21/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 08/21/2023 |
8-K
| Other Events Interactive Data |
| 08/10/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 08/10/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 07/24/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 07/24/2023 |
8-K
| Quarterly results |
| 07/11/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 06/28/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 06/15/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 06/15/2023 |
8-K
| Other Events Interactive Data |
| 05/15/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 05/11/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/08/2023 |
4
| SUBASI SAFAK (Senior Vice President) has filed a Form 4 on CNL Strategic Capital, LLC|
Txns:
| Bought 303 shares
@ $0 |
|
| 05/08/2023 |
4
| Drury Paul W (Senior Managing Director) has filed a Form 4 on CNL Strategic Capital, LLC|
Txns:
| Bought 2,248 shares
@ $33.36, valued at
$75k
|
|
| 05/08/2023 |
4
| SENEFF JAMES M JR (Director) has filed a Form 4 on CNL Strategic Capital, LLC|
Txns:
| Sold 303 shares
@ $0 |
|
| 04/24/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 04/24/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 04/21/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 04/21/2023 |
8-K
| Quarterly results |
| 04/13/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 03/29/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/27/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 03/27/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data|
Docs:
|
"CNL Strategic capital ACQUIRES majority stake in TacMED SOluTIONS March 27, 2023 — CNL Strategic Capital, LLC acquired a majority equity stake and made a concurrent debt investment in TacMed Solutions . At the closing of the transaction, all of the remaining TacMed equity is owned by members of TacMed’ s executive team and its founder. This is the 12th company in CNL Strategic Capital’ s portfolio. Founded in 2003 and headquartered in Anderson, South Carolina, TacMed designs, develops and manufactures medical products that equip, train and protect professionals in pre-hospital, emergency trauma situations. TacMed’ s suite of traumatic injury products, hemorrhage control tourniquets, immobilization tools and critical care kits serve first responders, military, law enforcement and civilian p..." |
|
| 03/17/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 03/17/2023 |
8-K
| Other Events Interactive Data |
| 02/24/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 02/24/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 12/16/2022 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 12/16/2022 |
8-K
| Quarterly results |
| 11/18/2022 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 11/18/2022 |
8-K
| Quarterly results |
| 11/14/2022 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 11/14/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 10/21/2022 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
|